SCHEMBL3072829

SCHEMBL3072829

O=[N+]([O-])c1cccc2oc(CO)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
GAA P10253 1/20 0.60
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 6/20 0.43
LMNA P02545 1/20 0.43
GPR35 Q9HC97 3/20 0.42
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
CSNK2A3 Q8NEV1 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.37
CTSB P07858 1/20 0.37
GABRP O00591 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8039855 0.76 MEN1 (1.00) MAPTMEN1KMT2AGAATDP1
SCHEMBL20125060 0.76 MAPT (0.66) MAPTMEN1KMT2AGAATDP1
SCHEMBL31634119 0.75 MAOA (0.56) MAPTMEN1KMT2AGAATDP1
SCHEMBL6176327 0.75 MAPT (0.65) MAPTMEN1KMT2AGAATDP1
SCHEMBL3085553 0.73 MAPT (0.62) MAPTMEN1KMT2AGAATDP1
SCHEMBL32679918 0.73 MAOA (0.41) MAPTMEN1KMT2ATDP1LMNA
SCHEMBL15828669 0.72 MEN1 (0.60) MAPTMEN1KMT2AGAATDP1
SCHEMBL5364833 0.71 ALDH1A1 (0.41) MAPTMEN1KMT2AGAATDP1
SCHEMBL16693135 0.71 IDO1 (0.37) MAPTGAAALDH1A1NPC1RAB9A
SCHEMBL8441084 0.71 HDAC6 (0.38) MAPTMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795255-B2 Rigidified compounds for modulating heparanase activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2010-09-14 US disclosed
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2008-02-14 US disclosed
EP-1846383-A2 RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY Insight Biopharmaceuticals Ltd. (IL) 2007-10-24 EP disclosed
WO-2006072953-A2 RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity HPSE, HEXA, GAA MAPT 2880/4885MEN1 3219/4885KMT2A 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.